XML 31 R18.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Note 13 - Segment Information | 6 Months Ended
--- | ---
Dec. 31, 2021
Notes to Financial Statements |
Segment Reporting Disclosure [Text Block] | Note 13. Segment Information: The Company's management evaluates segment operating performance based on operating income before certain charges to cost of sales and selling, general and administrative expenses, principally associated with the impact of partially owned consolidated subsidiaries as well as acquisition accounting related to inventory, amortization of acquisition-related intangible assets and other acquisition-related expenses. The Protein Sciences and Diagnostics and Genomics segments both include consumables, instruments, services and royalty revenue. The following is financial information relating to the Company's reportable segments (in thousands):
|  | Quarter Ended |  |  | Six Months Ended |
|  | December 31, |  |  | December 31, |
|  | 2021 |  |  | 2020 |  |  | 2021 |  |  | 2020 |
Net sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Protein Sciences |  | $ | 204,971 |  |  | $ | 172,179 |  |  | $ | 402,156 |  |  | $ | 326,625 |
Diagnostics and Genomics |  |  | 64,527 |  |  |  | 52,469 |  |  |  | 125,512 |  |  |  | 102,595 |
Intersegment |  |  | (222 | ) |  |  | (395 | ) |  |  | (673 | ) |  |  | (768 | )
Consolidated net sales |  | $ | 269,276 |  |  | $ | 224,253 |  |  | $ | 526,995 |  |  | $ | 428,452 |
Operating income: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Protein Sciences |  | $ | 93,281 |  |  | $ | 80,453 |  |  | $ | 183,381 |  |  | $ | 150,803 |
Diagnostics and Genomics |  |  | 10,880 |  |  |  | 8,107 |  |  |  | 18,344 |  |  |  | 16,781 |
Segment operating income |  | $ | 104,161 |  |  | $ | 88,560 |  |  | $ | 201,725 |  |  | $ | 167,584 |
Costs recognized on sale of acquired inventory |  |  | (84 | ) |  |  | (23 | ) |  |  | (1,595 | ) |  |  | (23 | )
Amortization of acquisition related intangible assets |  |  | (18,380 | ) |  |  | (15,027 | ) |  |  | (36,769 | ) |  |  | (30,528 | )
Impact of partially owned consolidated subsidiaries(1) |  |  | (1,004 | ) |  |  | (207 | ) |  |  | (2,567 | ) |  |  | (207 | )
Acquisition related expenses |  |  | 13,262 |  |  |  | (4,421 | ) |  |  | 15,618 |  |  |  | (4,558 | )
Eminence impairment |  |  | (18,715 | ) |  |  | - |  |  |  | (18,715 | ) |  |  | - |
Stock based compensation, inclusive of employer taxes |  |  | (14,815 | ) |  |  | (16,225 | ) |  |  | (28,675 | ) |  |  | (29,557 | )
Restructuring costs |  |  | (743 | ) |  |  | (142 | ) |  |  | (1,928 | ) |  |  | (142 | )
Corporate general, selling, and administrative expenses |  |  | (1,334 | ) |  |  | (1,520 | ) |  |  | (1,524 | ) |  |  | (2,482 | )
Consolidated operating income |  | $ | 62,348 |  |  | $ | 50,995 |  |  | $ | 125,570 |  |  | $ | 100,087 |
(1) Adjusted operating income for the second quarter and full year of fiscal 2021 have been updated for comparability to fiscal 2022 for the inclusion of the impact of partially owned consolidated subsidiaries on the Company’s adjusted operating income.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration